Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSThree Regulatory News (STEM)

Share Price Information for SThree (STEM)

Share Price is delayed by 15 minutes
Get Live Data
170.20    -0.20 (-0.12%)
Bid:
169.60
Ask:
170.40
Spread: 0.80 (0.472%)
Market Cap: £208.86m
STEM Live PriceLast checked at - London Stock Exchange

Intraday SThree Share Chart

Directorate Change

2 Apr 2024 12:10

RNS Number : 9781I
SThree plc
02 April 2024
 

2 April 2024

 

SThree plc

 

Directorate Change

 

SThree plc, the only global specialist talent partner focused on roles in Science, Technology, Engineering and Mathematics (STEM), is pleased to announce that it will appoint Sanjeevan Bala as an Independent Non-Executive Director with effect from the conclusion of the Annual General Meeting on 25 April 2024, in line with its previously stated plan to recruit a new Non-Executive.

 

Sanjeevan has extensive experience driving customer-centric technology transformation, having most recently been responsible for driving the digital data and AI transformation of the UK's largest commercial broadcaster and media company, ITV plc as the Group Chief Data and AI Officer. Prior to this, Sanjeevan was Head of Data Science at Channel 4 and held senior roles at Clear Cell Group and Dunhumby, a global leader in Customer Data Science.

 

Sanjeevan is currently a Non-Executive Director and the Designated Workforce Engagement NED at Bakkavor Group plc, Co-Chair of the Chief Data and AI Office Board at Evanta, a Gartner Company and on the Advisory Board of DataIQ.

 

On joining the Board, Sanjeevan will also be appointed as a member of the Audit & Risk, Nominations and Remuneration Committees.

 

James Bilefield, Chairman, commented: 

 

"I am delighted to welcome Sanjeevan to SThree and the Board. Sanjeevan is a highly experienced multi award-winning data and analytics professional with a proven track record of driving customer-centric business transformations through the strategic use of data. He brings with him extensive strategic and commercial experience which will be particularly relevant as we continue to roll out our Technology Improvement Programme, positioning us as game-changers in the market and demonstrating our ambition to be digital-first innovators. We look forward to working with him as the Group continues to execute its growth strategy."

 

 

Sanjeevan Bala commented:

 

"Having spent most of my career in STEM and witnessing first-hand the global demand for these skills expand exponentially, it feels like an incredibly exciting time to be joining SThree. The SThree team talks to global megatrends that underpin the demand for STEM and flexible talent and they couldn't be more correct. I look forward to working with the Board and forward-thinking leadership team to capitalise on this structural opportunity."

 

Notes:

This disclosure is given in accordance with LR 9.6.11 R of the Listing Rules. There is no further information to be disclosed pursuant to Listing Rule 9.6.13. 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUAUCUPCGGP
Date   Source Headline
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSFY25 Q1 Trading Update
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20253:45 pmRNSDirector/PDMR Shareholding
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20253:00 pmRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20254:45 pmRNSDirector/PDMR Shareholding
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 202512:30 pmRNSAnnual Financial Report
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20259:55 amRNSTotal Voting Rights
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSTransaction in Own Shares
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 202510:51 amRNSDirector/PDMR Shareholding
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20254:01 pmRNSBlock listing Interim Review
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20257:00 amRNSTransaction in Own Shares
18th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:00 amRNSTransaction in Own Shares
13th Feb 202510:35 amRNSDirector/PDMR Shareholding
13th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20254:36 pmRNSHolding(s) in Company
12th Feb 20257:00 amRNSTransaction in Own Shares
11th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.